APA (7th ed.) Citation

Poosti, F., Soebadi, M. A., Crijns, H., De Zutter, A., Metzemaekers, M., Berghmans, N., . . . Struyf, S. (2022). Inhibition of renal fibrosis with a human CXCL9‐derived glycosaminoglycan‐binding peptide. Clinical & Translational Immunology, 11(2), 1. https://doi.org/10.1002/cti2.1370

Chicago Style (17th ed.) Citation

Poosti, Fariba, et al. "Inhibition of Renal Fibrosis with a Human CXCL9‐derived Glycosaminoglycan‐binding Peptide." Clinical & Translational Immunology 11, no. 2 (2022): 1. https://doi.org/10.1002/cti2.1370.

MLA (9th ed.) Citation

Poosti, Fariba, et al. "Inhibition of Renal Fibrosis with a Human CXCL9‐derived Glycosaminoglycan‐binding Peptide." Clinical & Translational Immunology, vol. 11, no. 2, 2022, p. 1, https://doi.org/10.1002/cti2.1370.